Aclaris Therapeutics CEO Neal Walker's 2018 pay jumps 439% to $4.4M
Aclaris Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Aclaris Therapeutics reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, three executives at Aclaris Therapeutics received on average a compensation package of $2.8M, a 341% increase compared to previous year.
Average pay of disclosed executives at Aclaris Therapeutics
Neal Walker, Chief Executive Officer, received $4.4M in total, which increased by 439% compared to 2017. 60% of Walker's compensation, or $2.6M, was in option awards. Walker also received $221K in non-equity incentive plan, $550K in salary, $954K in stock awards, as well as $12K in other compensation.
David Gordon, MB ChB, Chief Medical Officer, received a compensation package of $2.1M. 63% of the compensation package, or $1.3M, was in option awards.
Stuart Shanler, Chief Scientific Officer, earned $1.8M in 2018, a 239% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2019.